The global cancer profiling market is witnessing remarkable growth as healthcare systems increasingly embrace precision medicine and advanced diagnostic technologies. Valued at US$ 13.4 billion in 2022, the market is projected to expand at a CAGR of 10.3% from 2023 to 2031, surpassing US$ 31.4 billion by the end of the forecast period. The growing prevalence of cancer worldwide, rising...